1,044 filings
Page 4 of 53
8-K
EYPT
EyePoint Pharmaceuticals Inc
8 Dec 23
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:02pm
4
Therapeutics OcuMension
7 Dec 23
EyePoint Pharmaceuticals / Therapeutics Ocumension ownership change
9:21pm
4
Ye Liu
7 Dec 23
EyePoint Pharmaceuticals / Ye Liu ownership change
9:03pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
7 Dec 23
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
6:11pm
424B5
EYPT
EyePoint Pharmaceuticals Inc
7 Dec 23
Prospectus supplement for primary offering
6:11am
4
Michael Craig Pine
6 Dec 23
EyePoint Pharmaceuticals / Michael Craig Pine ownership change
5:20pm
4
EYPT
EyePoint Pharmaceuticals Inc
6 Dec 23
EyePoint Pharmaceuticals / Dario A. Paggiarino ownership change
5:19pm
4
Nancy Lurker
6 Dec 23
EyePoint Pharmaceuticals / Nancy Lurker ownership change
5:18pm
4
Cormorant Global Healthcare Master Fund, LP
6 Dec 23
EyePoint Pharmaceuticals / Bihua Chen ownership change
4:39pm
3
Cormorant Asset Management, LP
6 Dec 23
EyePoint Pharmaceuticals / Bihua Chen ownership change
4:38pm
144
Therapeutics OcuMension
5 Dec 23
Notice of proposed sale of securities
8:54am
424B5
EYPT
EyePoint Pharmaceuticals Inc
4 Dec 23
Prospectus supplement for primary offering
5:31pm
144/A
Nancy Lurker
4 Dec 23
Notice of proposed sale of securities (amended)
4:34pm
144
EYPT
EyePoint Pharmaceuticals Inc
4 Dec 23
Notice of proposed sale of securities
4:16pm
144
Michael Craig Pine
4 Dec 23
Notice of proposed sale of securities
4:15pm
144
Nancy Lurker
4 Dec 23
Notice of proposed sale of securities
3:39pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
4 Dec 23
Other Events
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
9 Nov 23
Other Events
8:00am
10-Q
2023 Q3
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
3 Nov 23
3:47pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
1 Nov 23
EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments
7:05am